The increased activity of angiotensin II through the angiotensin II type I receptor (AT1R) can cause inflammation and the release of interleukin-6 (IL-6) and decrease in nitric oxide (NO) activity, causing endothelial dysfunction and increasing the risk of atherosclerosis [12]. This evidence concerns the gene IL6 and endothelial dysfunction.